Philip Starkey Lewis (@LiverStark205) header
Philip Starkey Lewis (@LiverStark205) profile picture

Principal Scientist and Co-founder of Resolution Therapeutics

Edinburgh, UK
Joined November 2023
Philip Starkey Lewis retweeted
NEW SIGNING 🚨 Please welcome back to the club, Jack Goodwin. Another pivotal cog in our Promotion winning machine; Jack is a twice PCFC Young Player of the Season winner and transfers from @MarineAFC in the National League North. Welcome back, @Jackgoodwin101
6
9
6
100
16,669
Philip Starkey Lewis retweeted
📢 Recruitment is now COMPLETE to both BOPPP & MBOP! 🥳🥳 A major THANK YOU from us to you ALL for your hard work to get us here! 💙💙💙 We exceeded our recruitment target with a TOTAL of 7️⃣6️⃣3️⃣ recruitment participants! A huge commitment - we couldn't have done it with you ALL!
8
13
5
55
6,657
Philip Starkey Lewis retweeted
Alcohol abstinence reduced #cirrhosis decompensation risk even in people with high portal pressure 1️⃣i ❤️good news 2️⃣study would have benefitted from peth 3️⃣👏👏first author Dr Hofer #livertwitter pubmed.ncbi.nlm.nih.gov/3648… @AGA_CGH
2
31
1
145
Philip Starkey Lewis retweeted
Precision mapping of a gut-brain circuit w/ functional impact. Glands in the small intestine (Brunner's) have GLP-1 receptors, are stress-sensitive, connect to the brain via the vagal nerve, modulate bacterial species in the gut microbiome, and regulate immunity cell.com/cell/fulltext/S0092… @CellCellPress
9
259
15
846
89,625
Cirrhosis of the liver still on the rise
Look how the leading causes of death in the US have changed over the past 4 years @JAMA_current jamanetwork.com/journals/jam…
10
Philip Starkey Lewis retweeted
What a day! Just finished my first ever @edfringe @CODIfringe performance. Brilliant questions from the audience and awesome support from @suziemo. Thanks to all for making this happen, such fun! @EdinUni_IRR
3
32
750
Philip Starkey Lewis retweeted
Another exciting day in IgA Nephropathy novartis.com/news/media-rele…
3
112
1
305
28,265
Incredible imaging
.@NASAJPL's Goldstone planetary radar had a busy few days observing two asteroids, designated #2024MK and #2011UL21, as they safely passed by Earth.
2
29
Philip Starkey Lewis retweeted
Today we have announced key data presentations with the @uniofedinburgh at the #EASL Congress 2024, held in Milan, Italy. The data highlights the significant potential of macrophage cell therapy for advanced liver cirrhosis. Read the full press release below.
2
4
3
11
1,089
Philip Starkey Lewis retweeted
Watch our CEO @amirhefni on #OptimumTV discussing the urgent need for new treatments for end-stage liver disease and our innovative macrophage cell therapy platform! Excited to present our poster at #EASL in Milan this week! Watch the episode below.
End-stage liver disease is a cruel illness, compounded by the scarcity of donor livers needed to extend life. In the latest edition of #OptimumTV with @ResolutionTx CEO @amirhefni, learn how the @EdinburghUni spin-out is developing a pioneering non-surgical treatment for end-stage #liver disease using autologous cell therapy. #ResolutionTherapeutics #OptimumStrategicCommunications
3
6
163
Philip Starkey Lewis retweeted
Our co-founder, Prof. Stuart Forbes from @EdinburghUni is presenting "Macrophage Therapy for Liver Disease" at the 3rd International Symposium on Regenerative Hepatology, organized by #EASL, in Milan today! 📅 Tuesday, 4 June | 🕔5 PM | 📍 Theatre 3 Don't miss it!
2
8
91
Philip Starkey Lewis retweeted
#LiverTwitter @EASLnews @AASLDtweets Save the date #BanenoVIII 27-28 March 2026 sign up for updates as a member for free: 🌐 bavenocoop.net/ @BavenoCoop
1
25
1
59
4,756
Philip Starkey Lewis retweeted
With deep sadness, AASLD recognizes the passing of a great leader in the field. Dr. Stephen Harrison leaves behind an incredible legacy, particularly in NASH/MASH. Thank you Drs. Rinella, Tetri, and Brunt for your moving tribute, which you can read here: aasld.org/col-stephen-harris…
6
49
2
155
18,563
Philip Starkey Lewis retweeted
So sad about the passing of Stephen Harrison, one of the most influential leaders in hepatology, and a great person. His legacy, including the first drug for MASLD, his talent and his kind demeanor will remain with us. #livertwitter @EASLnews @AASLDtweets
7
20
3
115
12,071
Philip Starkey Lewis retweeted
Tomorrow is #WorldLiverDay!
Liver disease poses a significant health and socio-economic burden globally, yet it lacks adequate attention on the global political agenda. There is low awareness about liver disease risk factors at the population level. Most liver diseases could be prevented. 🌎Let's spread awareness and address these gaps. 🎉 Celebrate #WorldLiverDay on 19 April, wherever in the world you are based. 👉worldliverday.org #liver #health #awareness @EASLnews @AASLDtweets @APASLnews @alehlatam @Solda_Society @AleksanderKrag @EASLEUAffairs @JHepatology @JVLazarus @EASLedu @FattyLiverA @GlobalLiver @LiverPatients @EuropeLiver
7
13
2,849
Philip Starkey Lewis retweeted
REVIEW: Mallet M et al. Current challenges and future perspectives in treating patients with NAFLD-related cirrhosis. #LiverTwitter tinyurl.com/5n6ctww5
7
9
2,080
Philip Starkey Lewis retweeted
What is in the pipeline to treat decompensated cirrhosis ? Can we use biomarkers to guide therapy ? This great review by giants in the field tells you all. t.ly/DRBav #livertwitter @JonelTrebicka @DebbieShawcros1 @ruben_hernaez @Gut_BMJ
20
1
58
5,059